Scar carcinoma of the lung: a historical perspective.
Bobba RK, Holly JS, Loy T, Perry MC.
Clin Lung Cancer. 2011 May;12(3):148-54. doi: 10.1016/j.cllc.2011.03.011. Epub 2011 Apr 24.
New progress of tuberculosis scar carcinoma.
Sun W, Liu Y, Zhao L, Wang H, Ye L, Liu X, Xu K, Chen Y, Fan L.
Cancer Metastasis Rev. 2023 Sep;42(3):653-659. doi: 10.1007/s10555-023-10128-9. Epub 2023 Aug 16.
Occult scar carcinoma of the lung with overt liver metastases and high serum CA 19-9 levels.
Lin YY, Cho SF.
J Postgrad Med. 2019 Oct-Dec;65(4):251-252. doi: 10.4103/jpgm.JPGM_145_19.
Collagens in scar carcinoma of the lung.
el-Torkey M, Giltman LI, Dabbous M.
Am J Pathol. 1985 Nov;121(2):322-6.
[Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
Zhang SY, Ruan JJ, Jin DM, Chen N, Xie WG, Ruan QF.
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023 Jun 20;39(6):518-526. doi: 10.3760/cma.j.cn501225-20230421-00137.
Adenosquamous carcinoma of the lung: radiologic appearance.
Kazerooni EA, Bhalla M, Shepard JA, McLoud TC.
AJR Am J Roentgenol. 1994 Aug;163(2):301-6. doi: 10.2214/ajr.163.2.8037019.
Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial.
Offersen BV, Alsner J, Nielsen HM, Jakobsen EH, Nielsen MH, Krause M, Stenbygaard L, Mjaaland I, Schreiber A, Kasti UM, Overgaard J; Danish Breast Cancer Group Radiation Therapy Committee.
J Clin Oncol. 2020 Nov 1;38(31):3615-3625. doi: 10.1200/JCO.20.01363. Epub 2020 Sep 10.
The changing pattern of lung carcinoma.
Auerbach O, Garfinkel L.
Cancer. 1991 Nov 1;68(9):1973-7. doi: 10.1002/1097-0142(19911101)68:9<1973::aid-cncr2820680921>3.0.co;2-z.
Scar cancers of the lung: origin and significance.
Madri JA, Carter D.
Hum Pathol. 1984 Jul;15(7):625-31. doi: 10.1016/s0046-8177(84)80286-5.
Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.
Travis WD, Garg K, Franklin WA, Wistuba II, Sabloff B, Noguchi M, Kakinuma R, Zakowski M, Ginsberg M, Padera R, Jacobson F, Johnson BE, Hirsch F, Brambilla E, Flieder DB, Geisinger KR, Thunnissen F, Kerr K, Yankelevitz D, Franks TJ, Galvin JR, Henderson DW, Nicholson AG, Hasleton PS, Roggli V, Tsao MS, Cappuzzo F, Vazquez M.
J Thorac Oncol. 2006 Nov;1(9 Suppl):S13-9.
